Collection
MeSH Terms
pancreatic neoplasms, carcinoma, pancreatic ductal, pancreatic ductal adenocarcinoma, pancreatic cancer, pancreas cancer, pancreas adenocarcinoma, adjuvant treatment, cancer adjuvant therapy, adjuvant therapy, resected pancreatic ductal adenocarcinoma, chemotherapy, adjuvant, antineoplastic agents, drug therapy, pancreas adenocarcinoma, pancreas carcinoma, pancreas tumor, adjuvant chemotherapy, adjuvant chemoradiotherapy
Keywords
pancreatic ductal adenocarcinoma, pancreatic cancer, adjuvant treatment, antineoplastic agents, adjuvant chemoradiotherapy
Date for Review
In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
Record Publish Year
2022
Publication Date
2022-06-20
Date of Last Evidence Search
2021-11-25
Methods Applied
Systematic review-based,
Externally reviewed,
Evidence quality assessment,
Patient/survivors/caregivers participation
Externally reviewed,
Evidence quality assessment,
Patient/survivors/caregivers participation
Guideline Contact
Roxanne Cosby; [email protected]
Publication Scope
Guidelines
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
PEBC (Program in evidenced-based care)
Publication Year
2022